SomaLogic soars 14% on team up with Illumina to develop proteomic solutions
SomaLogic (NASDAQ:SLGC) and Illumina (NASDAQ:ILMN) are collaborating to develop sequencing-based proteomic solutions.
The financial terms of the transaction were not disclosed.
The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership for proteomics and multi-omics research worldwide.

In partnership, the companies will develop co-exclusive, co-branded, next-generation sequencing (NGS)-based proteomics products.
Illumina will develop and deploy NGS-based protein identification and measurement tools into laboratories worldwide, and facilitate the development and use of high-plex protein pattern recognition tests.
SLGC +14.70% at $11.86 after-hours